As patients, families, and health professionals, you know that research is key to understanding, treating, and ultimately finding cures for aplastic anemia and other bone marrow failure diseases. We hear that many of you follow research developments very closely and frequently. We want to make it easy for you to do so.
- Watch our interview with Dr. Young. Dr. Neal Young of the National Heart, Lung & Blood Institute and a member of the AA&MDSIF Medical Advisory Board, highlighted research presented at the 2013 American Society of Hematology meeting. Dr. Young discusses some of the promising treatment possibilities likely to come in the next several years that should speed up the process by which patients can be treated for their aplastic anemia, including the development and testing of certain drugs such as Eltrombopag.
- Read the Summary. Drs. Neal Young and Danielle Townsley share information about aplastic anemia Clinical Trials at the National Institutes of Health.
- Read more from Dr. Stephanie Halene from Yale University School of Medicine. She reviewed an article about the pathophysiology and management of thrombocytopenia in bone marrow failure from the International Journal of Hematology.
- Read the summary from Johns Hopkins University’s Dr. Amy DeZern, who summarized research on the prognostic value of telomere attrition in patients with aplastic anemia.
- Read the summary by Kelsie Storm, MD and Phoenix Ho, MD of the North American Pediatric Aplastic Anemia Consortium Symposium meeting